Top
SPATA17 has not been detected as a mutational cancer driver

SPATA17
Ensembl id ENSG00000162814
Mutated samples
Coding Sequence 55 (0.8%)
Protein Affecting 36 (0.5%)
Mode of action Unclassified
Known driver No
Cancer type Signals (Biases)
Clust Clustered Mutations FM Functional Mutations Rec Recurrent Mutations
This plot shows the most recurrently mutated cancer types in all SPATA17 gene mutations. Each bar of the histogram indicates the amount of samples with PAMs.

Cancer type Driver Mutated samples (CS) Mutated samples (PAM) % Mutated samples (PAM)
Cutaneous melanoma No 10 7 1.90
Colorectal adenocarcinoma No 4 4 1.75
Head and neck squamous cell carcinoma No 6 4 1.07
Lung adenocarcinoma No 3 3 0.77
Breast carcinoma No 4 3 0.26
Lung squamous cell carcinoma No 4 3 1.72
Renal clear cell carcinoma No 3 3 0.72
Pancreas adenocarcinoma No 2 2 0.93
Esophageal carcinoma No 3 2 1.37
Bladder carcinoma No 2 1 1.02
Non small cell lung carcinoma No 1 1 3.23
Lower grade glioma No 1 1 0.59
Stomach adenocarcinoma No 2 1 0.62
Glioblastoma multiforme No 1 1 0.26
Hepatocarcinoma No 2 0 0.00
Chronic lymphocytic leukemia No 6 0 0.00
Pylocytic astrocytoma No 1 0 0.00
The mutations needle plot shows the distribution of the observed cancer mutations along the protein sequence and it's possible mutational clusters and hotspots. The needles' height and head size represent mutational recurrence. Needles of different categories that fall in the same amino acid residues are stacked.

Variant Locus Samples AA pos AA change Consequence